popular wires

Very few companies are currently experiencing what could be regarded as a normal operating environment. Other than utilities and other providers of staple goods or...

Small and micro cap companies have largely finished reporting their full year results to the market. Online retail and consumer facing Fin Tech firms have been market ...

As many would agree a good funds manager looks for undervalued assets, injects the right level of capital along with sound management initiatives to create...

Local market played chase the currency all day to finish negative. Lower turnover than last week meant Global investors had even bigger effect. The main game is the...

Join us as we discuss the ongoing impacts of the coronavirus, and whether Australia's global leading household debt levels may fuel a protracted downturn in our...

Retail has been one of the surprise winners from the pandemic, capturing the attention of savvy investors. But just as important as identifying winners, is avoiding...

While the conduct of monetary policy in China is converging on what are established norms in advanced countries, in many ways it is still quite different. It is these...

We have previously highlighted the role of robotics and artificial intelligence (A.I.) technologies in fighting the spread of COVID-19 in an article published on 15th...

The August 2020 reporting season was always going to be very unusual, dominated not by company-specific factors, but instead by rising political tensions,...

In our previous collections piece, our trio of residential housing experts explained the state of play for the Australian housing market after the detrimental impact...

Who doesn’t adore the so-called “Comeback Kings”? These are companies that were stuck in a miserable rut and written-off by the market… only to then soar back to...

Remember when debt was debt. Those were the days. When if you didn’t have the cash you didn’t buy anything. When there was a thing called “Saving up”. Remember that?...

Over the last few years, Paradigm Biopharmaceuticals (PAR) has grown from an unknown small cap to a $600 million dollar drug developer. With trials and approvals...

A monthly wrap-up of interesting and informative media on finance, economics, politics and society that you might have missed. Finance Citigroup helped Revlon dupe its...

On Wednesday 26 August, two mid-cap companies made announcements – grocery wholesaler Metcash held its annual general meeting, while financial technology company Zip...

A common debate amongst investors is how many investments are required in an equity portfolio to provide adequate diversification, where the key objective of...

Welcome to the FNArena Reporting Season Monitor for the August result season 2020. The Monitor reports ratings and consensus price target changes, along with brief...

Headlines in recent weeks have touted an about-turn by Warren Buffett as he finally bought gold after years of criticising. But is that really what happened? In this...

Artificial intelligence giant Appen notched up a miss on Thursday. But are the company’s lacklustre EBITDA results just a consequence of an unpredictable market and a...

If there was such a thing as a fairy tale in an investment context, the ASX’s tech darling Afterpay (ASX:APT) would no doubt be a worthy poster child. For investors...